BIRC5 and juvenile idiopathic arthritis: It could be speculated that it is possible that these children in the future could present JIA symptoms as survivin occurs before clinical manifestation, even in the pre-antibody period. As in our study group the percentage of children with JIA does not correspond to the prevalence of JIA in the general population thus PPV and NPV were not calculated.